Recent Finacing
Recent Raise
Imvaq Therapeutics develops armed vaccinia and MVA viral immunotherapies for solid tumors, using a cGAS/STING screen to remove immune-evasion genes and add immunostimulatory transgenes, advancing MQ710 to Phase 1.
Focus Areas
Recent Investors
Total Raised
Funding round
Investor
See the team members at IMVAQ Therapeutics.
